Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, CA

Clinical Trial Details


Research Study Summary

Schizophrenia Outpatient Clinical Research Study


The purpose of the research is to test safety and efficacy and effectiveness of an investigational drug and to determine its effect on weight gain compared to patients taking Abilify. Patients may require initiation or modification to current antipsychotic treatment. Participation in the study would be expected to last a total of 52 weeks.

Patient Inclusion Criteria:

  • Must be 18-65 years of age with a diagnosis of Schizophrenia

Patient Exclusion Criteria:

  • No Abilify use in the last two months
  • No drug or alcohol abuse in the last 3 months prior to Visit 1
  • No unstable medical condition
  • No hepatitis or seizure history

To Learn more

Both Male and Female


18 to 65 Years

Overall Status



52 Weeks

Facility Type



Schuster Medical Research Institute
5000 Van Nuys Blvd., Suite 216
Sherman Oaks, CA 91403
Phone: (818) 788-0746
Fax: (818) 788-0742

View Map

Research Center Information: Schuster Medical Research Institute

CW ID: 179144

Date Last Changed: July 19, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.